Pharmaceuticals

Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down

Supplements of this hormone are sold to increase sex drive. But the change may be tiny

An analysis found that, following Trump’s claim that acetaminophen was linked to autism, orders for the drug for pregnant patients in emergency rooms dropped, while the number of children prescribed an unproven autism treatment increased

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths

A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it

Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results

The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy experts say could raise safety risks

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much

Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race.

A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than people who stop dieting or exercising

The first GLP-1 pills for weight loss are hitting U.S. pharmacies. But how will they be prescribed?